Diagonal Therapeutics (Series B)
Funding Details
Awarder
RSS - feeds.feedburner.com
Date Award
January 12, 2026
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount
$125,000,000
Company Info
Organizations Involved
Sanofi Ventures, Janus Henderson Investors
Market
Severe genetic diseases
Location
Watertown, MA, USA
Coinvestors
Sanofi Ventures, Janus Henderson Investors, Deep Track Capital, EcoR1 Capital, Logos Capital, Balyasny Asset Management L.P., Woodline Partners LP, Atlas Venture, BVF Partners, Lightspeed Venture Partners, RA Capital Management, Frazier Life Sciences, Viking Global Investors, RV Invest, Velosity Capital, Biovision Ventures, Checkpoint Capital
Company Description

Diagonal Therapeutics is a biotechnology company developing disease-modifying clustering antibodies that correct dysregulated signaling in severe genetic diseases.

Links
Website
Back to HomeBack to Biotechnology DealsView Funding Announcement